We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Skye Bioscience
SKYE
$7.04M
| $3.5M | ﹤0.01% |
104,745
-14,427
| -12% | -$239K |
2024 Q2
4 quarters
|
|
3327
Instil Bio
TIL
$41.6M
| $3.5M | ﹤0.01% |
168,098
| – | – |
2021 Q1
17 quarters
|
|
|
NGD
3328
DELISTED
New Gold Inc
NGD
| $3.49M | ﹤0.01% |
703,080
| – | – |
2015 Q1
41 quarters
|
|
3329
UroGen Pharma
URGN
$1.79B
| $3.49M | ﹤0.01% |
254,971
+4,542
| +2% | +$43.6K |
2023 Q2
8 quarters
|
|
3330
Neumora Therapeutics
NMRA
$80.2M
| $3.49M | ﹤0.01% |
4,762,903
-562,134
| -11% | -$426K |
2023 Q3
7 quarters
|
|
3331
Pliant Therapeutics
PLRX
$60.2M
| $3.48M | ﹤0.01% |
3,002,348
-332,227
| -10% | -$469K |
2020 Q2
20 quarters
|
|
3332
Research Solutions
RSSS
$68.2M
| $3.48M | ﹤0.01% |
1,212,076
+18,808
| +2% | +$51.5K |
2020 Q2
20 quarters
|
|
3333
Jasper Therapeutics
JSPR
$17.7M
| $3.47M | ﹤0.01% |
624,597
-54,855
| -8% | -$270K |
2021 Q4
14 quarters
|
|
3334
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$49.3B
| $3.47M | ﹤0.01% |
96,713
-2,612
| -3% | -$87.1K |
2023 Q1
9 quarters
|
|
3335
DELISTED
Leslie's
LESL
| $3.46M | ﹤0.01% |
412,202
-93,237
| -18% | -$1.23M |
2020 Q4
18 quarters
|
|
3336
Establishment Labs
ESTA
$1.83B
| $3.45M | ﹤0.01% |
80,893
-396
| -0.5% | -$13.8K |
2019 Q2
24 quarters
|
|
3337
Kestrel Group
KG
$36.1M
| $3.44M | ﹤0.01% |
129,870
-10,882
| -8% | -$252K |
2013 Q2
48 quarters
|
|
3338
Gaia
GAIA
$34.3M
| $3.44M | ﹤0.01% |
784,329
+144,008
| +22% | +$656K |
2013 Q2
48 quarters
|
|
3339
DELISTED
Synchronoss Technologies
SNCR
| $3.44M | ﹤0.01% |
502,292
+74,927
| +18% | +$622K |
2018 Q4
26 quarters
|
|
3340
Isabella Bank
ISBA
$280M
| $3.42M | ﹤0.01% |
+113,385
| New | +$3.43M |
2025 Q2
0 quarters
|
|
3341
Torrid Holdings
CURV
$244M
| $3.41M | ﹤0.01% |
1,156,725
+61,974
| +6% | +$325K |
2021 Q3
15 quarters
|
|
3342
AirSculpt Technologies
AIRS
$102M
| $3.41M | ﹤0.01% |
706,252
+104,972
| +17% | +$356K |
2021 Q4
14 quarters
|
|
3343
Richtech Robotics
RR
$320M
| $3.41M | ﹤0.01% |
1,747,501
-1,469,700
| -46% | -$3.09M |
2024 Q3
3 quarters
|
|
3344
Biomea Fusion
BMEA
$60.6M
| $3.38M | ﹤0.01% |
1,879,690
+501,626
| +36% | +$966K |
2021 Q2
16 quarters
|
|
3345
Wolfspeed
WOLF
$1.37B
| $3.38M | ﹤0.01% |
8,464,252
-10,449,541
| -55% | -$23.8M |
2013 Q2
48 quarters
|
|
3346
Hennessy Advisors
HNNA
$82.4M
| $3.37M | ﹤0.01% |
267,645
+18,215
| +7% | +$195K |
2014 Q4
42 quarters
|
|
3347
Nordic American Tanker
NAT
$1.66B
| $3.37M | ﹤0.01% |
1,280,548
+79,586
| +7% | +$208K |
2013 Q2
48 quarters
|
|
3348
Real REMAX Group Inc. Common Stock
REAX
$348M
| $3.36M | ﹤0.01% |
74,560
+7,378
| +11% | +$317K |
2024 Q2
4 quarters
|
|
3349
DELISTED
Trinseo
TSE
| $3.36M | ﹤0.01% |
1,076,651
+115,899
| +12% | +$382K |
2014 Q3
43 quarters
|
|
3350
BGSF Inc
BGSF
$46.5M
| $3.36M | ﹤0.01% |
527,160
| – | – |
2016 Q2
36 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.